Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

By LabMedica International staff writers
Posted on 12 May 2026

Dementia places a substantial burden on patients and health systems, and identifying individuals at elevated risk remains difficult at scale. More...

In the UK, almost a million people are estimated to be living with the condition, underscoring the need for accessible screening approaches. Remote tools that combine biological signals with cognitive measures may help triage who needs further assessment. A new study shows that an at-home finger-prick blood test paired with online brain testing may help stratify dementia risk.

Researchers at the University of Exeter evaluated an at-home approach that pairs a finger-prick capillary blood test—returned to a laboratory by post—with online cognitive assessments completed from home. The method integrates remote collection of a small blood sample with unsupervised tests targeting memory, attention, and executive function. It is designed to link circulating protein markers associated with dementia to performance on standardized cognitive tasks completed via the internet.

The team worked within the online PROTECT study, in which more than 30,000 UK participants aged over 40 undertake regular cognitive testing. In this investigation, 174 PROTECT participants administered the at-home finger-prick test themselves and mailed samples for analysis. The researchers quantified two proteins: p-tau217, which is linked to Alzheimer’s disease, and GFAP, linked to broader brain decline. Performance on the online brain tests correlated with both blood markers, with tau showing the strongest associations, enabling classification of participants into low, medium, and high risk categories.

The study was published online in Nature Communications on May 6, 2026. It was led by the University of Exeter and funded by the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre, with additional support from the NIHR HealthTech Research Centre in Brain Health and the NIHR Applied Research Collaboration South West (PenARC). The researchers conclude that at-home testing could help identify those at highest risk for prioritization to further testing, treatment, and support, while also indicating individuals at low risk who could be reassured and those at moderate risk who may benefit from monitoring and risk-reduction guidance.

“Our previous research has shown that a finger-prick blood test can effectively be taken at home and posted to labs, and that we can identify the biomarkers in blood linked to dementia. This new study builds on that to show that we can link these biomarkers with performance on brain tests, giving us a potential way to predict risk of dementia,” said Professor Anne Corbett, of the University of Exeter Medical School.

“The potential of this combination of cognitive and blood tests, both of which can be done at home, is really exciting. Not only could it reduce the burden on the NHS by screening people in their own homes rather than in hospitals or clinics, but it also might mean we can identify people with dementia earlier, tailor treatments more effectively, and improve outcomes for patients. This is a fantastic example of research teams in NIHR infrastructure working together to deliver real change for the public and the NHS, in line with government priorities,” said Professor Marian Knight, NIHR Scientific Director for NIHR Infrastructure.

Related Links
University of Exeter Medical School


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.